Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma.
Toledo SP, Lourenço DM Jr, Santos MA, Tavares MR, Toledo RA, Correia-Deur JE.
Clinics (Sao Paulo). 2009;64(7):699-706. doi: 10.1590/S1807-59322009000700015.
[How to interprete hypercalcitoninemia?].
Levy-Bohbot N, Patey M, Larbre H, Hecart AC, Caron J, Delemer B.
Rev Med Interne. 2006 Aug;27(8):610-5. doi: 10.1016/j.revmed.2006.02.010. Epub 2006 Apr 19.
[Hypercalcitoninemia in conditions other than medullary cancers of the thyroid].
Niccoli P, Conte-Devolx B, Lejeune PJ, Carayon P, Henry JF, Roux F, Wion-Barbot N, Bigorgne JC.
Ann Endocrinol (Paris). 1996;57(1):15-21.
Hypercalcitoninemia in infancy.
Cannarozzi DB, Canale DD, Donabedian RK.
Clin Chim Acta. 1976 Feb 2;66(3):387-92. doi: 10.1016/0009-8981(76)90238-2.
[Medullary thyroid carcinomas: persistent hypercalcitoninemia after surgery, reoperations-results].
Proye C.
Ann Chir. 2003 Jun;128(5):289-92. doi: 10.1016/s0003-3944(03)00093-2.
Hypercalcitoninemia and thyroid nodules: when cytology (still) matters.
Giovanella L, Giugliano G, Maffini FA, Chiesa F, Bongiovanni M.
Diagn Cytopathol. 2014 Nov;42(11):970-3. doi: 10.1002/dc.23102. Epub 2014 Feb 18.
Hypercalcitoninism without hypercalcitoninemia.
Rostkowski CM, Wilson TD, Allan GS, Deftos LJ, Benson KW, Kallfelz FA, Minor RR, Krook L.
Cornell Vet. 1981 Apr;71(2):188-213.
Hypercalcitoninemia in acute pancreatitis.
Canale DD, Donabedian RK.
J Clin Endocrinol Metab. 1975 Apr;40(4):738-41. doi: 10.1210/jcem-40-4-738.
Hypercalcitoninemia, nodular goiter, and pancreatic tumor.
Ghnassia JP, Lindner V, Schneegans O, Haegelé P.
Thyroid. 1999 Jun;9(6):599-600. doi: 10.1089/thy.1999.9.599.
Spurious hypercalcitoninemia in patients with nodular thyroid disease induced by heterophilic antibodies.
Kim JM, Chung KW, Kim SW, Choi SH, Min HS, Kim JN, Won WJ, Kim SK, Lee JI, Chung JH, Kim SW.
Head Neck. 2010 Jan;32(1):68-75. doi: 10.1002/hed.21145.
